g
jr
born
november
23
1957
nobel
laureate
physician
scientist
professor
medicine
harvard
university
dana
farber
cancer
institute
laboratory
study
tumor
suppressor
protein
2016
received
lasker
award
basic
medical
research
aacr
princess
takamatsu
award
also
nobel
prize
physiology
medicine
2019
along
j
l
born
new
york
city
november
23
1957
earned
bachelor
degree
mathematics
chemistry
duke
university
stayed
attain
md
graduating
1982
residency
internal
medicine
john
school
medicine
fellowship
oncology
dana
farber
cancer
institute
dfci
deciding
undergraduate
research
strength
dfci
research
lab
livingston
found
success
study
retinoblastoma
1992
set
lab
dfci
hall
livingston
investigated
hereditary
form
cancer
hippel
lindau
disease
became
professor
harvard
medical
school
2002
became
assistant
director
basic
dana
farber
harvard
cancer
center
2008
research
dana
farber
focused
understanding
role
mutation
tumor
suppressor
gene
cancer
development
major
work
retinoblastoma
hippel
lindau
p53
tumor
suppressor
gene
work
funded
institute
health
cancer
society
duke
charitable
foundation
others
serf
vice
chair
scientific
program
damon
runyon
cancer
research
foundation
board
director
chair
damon
runyon
physician
scientist
training
award
selection
committee
member
board
director
eli
lilly
stand
cancer
scientific
advisory
committee
following
post
doctorate
set
laboratory
dana
farber
1993
continue
research
tumor
suppression
become
interested
von
hippel
lindau
disease
vhl
vhl
tumor
caused
gene
mutation
known
angiogenic
creating
blood
vessel
secreted
erythropoietin
epo
hormone
known
part
body
mechanic
react
hypoxia
low
oxygen
level
blood
hypothesized
may
connection
formation
vhl
tumor
deficiency
body
detect
oxygen
research
found
vhl
subject
gene
expressed
formation
protein
critical
epo
process
mutation
suppressed
work
aligned
j
separately
identified
two
part
protein
hypoxia
inducible
factor
hif
essential
epo
production
triggered
oxygen
level
blood
work
found
vhl
protein
would
help
regulate
hif
subject
vhl
protein
present
hif
would
overproduce
epo
lead
cancer
combined
work
identified
pathway
cell
detect
react
oxygen
level
blood
led
development
drug
help
patient
anaemia
kidney
failure
married
breast
cancer
surgeon
carolyn
1988
death
glioblastoma
2015
two
child
